Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction

Maurizio Ferrario, Piera Angelica Merlini, Stefano Lucreziotti, Arnaldo Poli, Francesco Cantù, Giuseppe Gobbi, Ezio Bramucci, Antonio Mussini, Diego Ardissino

Research output: Contribution to journalArticlepeer-review


Unstable angina and non-Q-wave myocardial infarction still represent an unsolved problem for clinicians, owing to their unpredictable evolution and high incidence of coronary events in the follow-up. Traditional antithrombotic agents, unfractionated heparin and aspirin, have been proved to be highly effective, but show some important limitations. New potent antithrombotic therapy have been studied to improve their efficacy, with encouraging results. Among these drugs, low molecular weight heparins (for subcutaneous administration) and inhibitors of platelet glycoprotein receptor IIb/IIIa (for intravenous, and possibly oral, administration) are the most promising and are now under extensive investigation.

Original languageEnglish
JournalInternational Journal of Cardiology
Issue numberSUPPL. 1
Publication statusPublished - Apr 10 1999


  • Anticoagulants
  • Antiplatelets
  • Non-Q-wave myocardial infarction
  • Unstable angina

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction'. Together they form a unique fingerprint.

Cite this